Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

2.4K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.4K
RNA Splicing01:32

RNA Splicing

61.0K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
61.0K
Alternative RNA Splicing02:18

Alternative RNA Splicing

25.4K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.4K
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

8.1K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
8.1K
Pre-mRNA Processing: RNA Splicing01:36

Pre-mRNA Processing: RNA Splicing

7.2K
7.2K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

The mechanism of intestinal IgA class switching regulated by TRIM21 through down-regulation of AID in IgA nephropathy.

International immunopharmacology·2026
Same author

<i>Ex vivo</i> bradykinin as a functional biomarker for angioedema with normal C1-inhibitor.

The journal of allergy and clinical immunology. Global·2026
Same author

Association of endothelial activation and stress index with all-cause and cardiovascular mortality in patients with diabetic kidney disease: a population-based prospective study.

Diabetology & metabolic syndrome·2026
Same author

RETRACTED ARTICLE: AI-Empowered assistive technology for optimizing specimen submission in obstetrics and gynecology: integrating DeepSeek with the ADDIE model.

Disability and rehabilitation. Assistive technology·2025
Same author

Bradykinin measurement by liquid chromatography tandem mass spectrometry in subjects with hereditary angioedema enhanced by cold activation.

The journal of allergy and clinical immunology. Global·2025
Same author

Vamp3/syntaxin 4 mediates the basolateral membrane fusion of TfR transcytosis across the BBB and is exploited by pathogenic <i>E. coli</i>.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same journal

A viral ORFeome library for systems-level genetic dissection of host-pathogen interactions.

Cell·2026
Same journal

Co-option of lysosomal machinery shapes the evolution of the intracellular photosymbiosis supporting coral reefs.

Cell·2026
Same journal

LEF1 and niche factors determine T cell stemness across chronic diseases.

Cell·2026
Same journal

Recurrent patterns of TOP1-mediated neuronal genomic damage shared by major neurodegenerative disorders.

Cell·2026
Same journal

Four-dimensional molecular mapping from a spatial snapshot reveals the dynamics of hair follicle organogenesis.

Cell·2026
Same journal

Whole-cell particle-based digital twin simulations from 4D lattice light-sheet microscopy data.

Cell·2026
Ver todos los artículos relacionados
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Feb 27, 2026

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts
07:02

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts

Published on: May 11, 2018

14.5K

Terapia de corrección de empalme para la AME

Lili Wan1, Gideon Dreyfuss1

  • 1Howard Hughes Medical Institute, Department of Biochemistry and Biophysics, University of Pennsylvania, School of Medicine, Philadelphia, PA 19104, USA.

Cell
|July 1, 2017
PubMed
Resumen
Este resumen es generado por máquina.

La atrofia muscular espinal (AMS) es una enfermedad genética causada por la baja proteína SMN. El tratamiento antisenso dirigido al silenciador de empalme de intrón 7 SMN2 puede mejorar la expresión de SMN y la función motora en pacientes con AME.

Más Videos Relacionados

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice
05:55

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice

Published on: October 3, 2011

63.5K
Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
10:28

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

7.2K

Videos de Experimentos Relacionados

Last Updated: Feb 27, 2026

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts
07:02

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts

Published on: May 11, 2018

14.5K
Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice
05:55

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice

Published on: October 3, 2011

63.5K
Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
10:28

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

7.2K

Área de la Ciencia:

  • La genética
  • Biología molecular
  • La neurociencia

Sus antecedentes:

  • La atrofia muscular espinal (SMA) es el resultado de una deficiencia en la proteína de la neurona motora de supervivencia (SMN), esencial para la biogénesis del spliceosoma.
  • La mayoría de los pacientes con AME poseen deleciones de SMN1, dependiendo de SMN2 como su principal fuente de proteína SMN.
  • Una sustitución específica de C a T en SMN2 altera el empalme mediante la conversión de un potenciador de empalme exónico (ESE) en un silenciador de empalme exónico (ESS), lo que lleva al salto del exón 7.

Objetivo del estudio:

  • Investigar el potencial terapéutico de dirigir el gen SMN2 para el tratamiento de la atrofia muscular espinal.
  • Evaluar la eficacia del tratamiento antisentido dirigido al silenciador de empalme de intrones SMN2 (ISS) para mejorar la expresión de SMN y la función motora.

Principales métodos:

  • Análisis de la deficiencia de proteína SMN en la atrofia muscular espinal (SMA).
  • Investigación del mecanismo molecular del salto del exón 7 en el pre-ARNm SMN2 debido a una sustitución de C a T.
  • Aplicación de un tratamiento antisenso dirigido al silenciador de empalme de intrones SMN2 (ISS).

Principales resultados:

  • Se demostró que el tratamiento antisenso dirigido al silenciador de empalme de intrones SMN2 (ISS) mejora la expresión de SMN.
  • El tratamiento también condujo a mejoras en la función motora en pacientes con AME.

Conclusiones:

  • El objetivo del silenciador de empalme de intrones SMN2 (ISS) con tecnología antisense representa una estrategia terapéutica prometedora para la atrofia muscular espinal (SMA).
  • Este enfoque puede mejorar efectivamente los niveles de proteína SMN y mejorar los déficits motores, ofreciendo una posible vía de tratamiento para los pacientes con AME.